MannKind | MNKD - Crediti Commerciali





Crediti Commerciali Cambiamento Data
Adma Biologics USD 135.86M 22.57M 2026-03
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Insmed USD 215.32M 36.77M 2026-06
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
MannKind USD 43.21M 15.07M 2026-06
Merck USD 12.21B 435M 2026-03
Novavax USD 106.45M 72.27M 2025-12
Novo Nordisk DKK 17.56B 82.7B 2026-06
Pfizer USD 16.19B 19M 2026-06
Sanofi EUR 492M 10M 2026-06
Xencor USD 42.23M 30.23M 2026-06